A polymorphism but no mutations in the GADD45 gene in breast cancers
Data up to Jan 2025
Total Citations Per Year
Abstract
References (39)
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
1990 • 3,896 citations
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
1990 • 3,720 citations
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
1994 • 3,536 citations
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
1992 • 3,110 citations
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
1992 • 3,092 citations
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
1994 • 2,025 citations
Definition of a consensus binding site for p53
1992 • 2,000 citations
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
1993 • 1,445 citations
Clinical Implications of the p53 Tumor-Suppressor Gene
1993 • 1,341 citations
Incidence of Cancer in 161 Families Affected by Ataxia–Telangiectasia
1991 • 944 citations
Interaction of the p53-Regulated Protein Gadd45 with Proliferating Cell Nuclear Antigen
1994 • 941 citations
Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents.
1993 • 770 citations
Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents.
1989 • 698 citations
Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.
1993 • 565 citations
Induction of cellular p53 activity by DNA-damaging agents and growth arrest.
1993 • 440 citations
Absence of WAF1 mutations in a variety of human malignancies
1994 • 390 citations
Multifactorial analysis of p53 alteration in human cancer: A review
1994 • 359 citations
Genomic Amplification with Transcript Sequencing
1988 • 324 citations
Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway.
1994 • 275 citations
Induction by ionizing radiation of the gadd45 gene in cultured human cells: lack of mediation by protein kinase C.
1991 • 268 citations
The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia.
1994 • 253 citations
Ataxia-Telangiectasia
1991 • 238 citations
Analysis of the mammalian gadd45 gene and its response to DNA damage.
1993 • 231 citations
The p53-dependent gamma-ray response of GADD45.
1994 • 225 citations
Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis.
1991 • 225 citations
Domains required for in vitro association between the cellular p53 and the adenovirus 2 E1B 55k proteins
1990 • 207 citations
Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents.
1993 • 201 citations
Altered Patterns of MDM2 and TP53 Expression in Human Bladder Cancer
1994 • 192 citations
Genotoxic‐Stress‐Response Genes and Growth‐Arrest Genes
1992 • 183 citations
Identification of the p53 protein domain involved in formation of the simian virus 40 large T-antigen-p53 protein complex
1986 • 175 citations
p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers.
1995 • 108 citations
Oncogene Amplification in Urothelial Cancers With p53 Gene Mutation or MDM2 Amplification
1994 • 97 citations
Pattern of p53 Gene Mutations in Breast Cancers of Women of the Midwestern United States
1992 • 94 citations
REPORTS
1991 • 92 citations
Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer.
1995 • 89 citations
Genetic changes in epithelial solid neoplasia.
1994 • 84 citations
DNA damage increases the levels of MDM2 messenger RNA in wtp53 human cells.
1994 • 74 citations
p53 gene mutations in breast cancers in midwestern US women: null as well as missense-type mutations are associated with poor prognosis.
1994 • 67 citations
Phage Promoter-Based Methods for Sequencing and Screening for Mutations
1994 • 10 citations